CIDRAP newsletters options
Vaccines must promote mucosal immunity to prevent infection by respiratory viruses and limit spread.
In other developments, Quest Diagnostics will introduce an H5 molecular test by the end of the month, which should increase testing capacity.
Federal investigators are looking at ground beef and slivered onions as potential sources of the outbreak.
Ten percent of newborns in the COVID-19 group had abnormalities, compared with 4% in the control group.
To date, 442,855 children under 10 years have been successfully vaccinated in central and south Gaza.
Global cholera deaths in 2024 are up 126% compared with 2023.
Of all children requiring ICU care, 16% were diagnosed as having multisystem inflammatory syndrome in children.
One clade of eight RSV-B genomes had a mutation tied to resistance to the monoclonal antibody nirsevimab.
The case-patient recently traveled abroad, but few other details were given by the institute.
The variant appears to have greater infectivity and immune-evasion properties, which could help it edge out KP.3.1.1.
The virus has an enzyme that can efficiently circumvent a host cell's innate defense mechanism.
Two patients who were intubated for multiple organ failure were successfully extubated, thought to be a first in Africa for Marburg.
The spurt of infections in Washington state is reminiscent of what Colorado experienced over the summer with illnesses in poultry cullers.
The authors said they observed distinct regional patterns to norovirus outbreaks in the state.
After surging during the pandemic, rates of carbapenem-resistant gram-negative bacteria in critically ill patients have declined but remain higher than pre-pandemic rates.
The Italian government will contribute $21 million over 3 years to support CARB-X’s efforts to advance early-stage development of innovative new products for drug-resistant pathogens.
The probe detected the biomarker for H5N1 at three treatment plants, with two confirming that animal protein had already left processing facilities such as dairy farms.
Safety and immunogenicity profiles were similar to those seen in adult studies.
The authors said the findings should encourage people to get vaccinated against RSV this year.
The unadjusted median time to symptom resolution was 10 days in both the intervention and placebo groups.
